-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Initiates Coverage On Radiopharm Theranostics with Buy Rating, Announces Price Target of $15

Benzinga·03/12/2025 09:36:20
Listen to the news
B. Riley Securities analyst Yuan Zhi initiates coverage on Radiopharm Theranostics (NASDAQ:RADX) with a Buy rating and announces Price Target of $15.